DE60316291D1 - Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung - Google Patents
Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtungInfo
- Publication number
- DE60316291D1 DE60316291D1 DE60316291T DE60316291T DE60316291D1 DE 60316291 D1 DE60316291 D1 DE 60316291D1 DE 60316291 T DE60316291 T DE 60316291T DE 60316291 T DE60316291 T DE 60316291T DE 60316291 D1 DE60316291 D1 DE 60316291D1
- Authority
- DE
- Germany
- Prior art keywords
- hyaluronic acid
- ester derivatives
- hydrogelic
- painting
- photo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/043—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002PD000064A ITPD20020064A1 (it) | 2002-03-12 | 2002-03-12 | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
ITPD20020064 | 2002-03-12 | ||
PCT/EP2003/002538 WO2003076475A1 (en) | 2002-03-12 | 2003-03-12 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60316291D1 true DE60316291D1 (de) | 2007-10-25 |
DE60316291T2 DE60316291T2 (de) | 2008-06-05 |
Family
ID=27799887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60316291T Expired - Lifetime DE60316291T2 (de) | 2002-03-12 | 2003-03-12 | Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung |
Country Status (10)
Country | Link |
---|---|
US (3) | US7462606B2 (de) |
EP (1) | EP1519962B1 (de) |
JP (1) | JP4458852B2 (de) |
AT (1) | ATE373018T1 (de) |
AU (1) | AU2003227050B2 (de) |
CA (1) | CA2478655C (de) |
DE (1) | DE60316291T2 (de) |
ES (1) | ES2294305T3 (de) |
IT (1) | ITPD20020064A1 (de) |
WO (1) | WO2003076475A1 (de) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITPD20020064A1 (it) * | 2002-03-12 | 2003-09-12 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
US6982298B2 (en) | 2003-01-10 | 2006-01-03 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US8138265B2 (en) | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US8137688B2 (en) | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US7465766B2 (en) | 2004-01-08 | 2008-12-16 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
ITPD20040053A1 (it) * | 2004-02-27 | 2004-05-27 | Fidia Advanced Biopolymers Srl | Biomateriali costituiti da derivati dell'acido ialuronico come nuova terapia di cura per la protezione e la la riparazione della cartilagine articolare danneggiata per osteoartrosi |
AU2005272578A1 (en) * | 2004-08-13 | 2006-02-23 | Angiotech International Ag | Compositions and methods using hyaluronic acid and hyluronidase inhibitors |
US9205047B2 (en) * | 2005-04-25 | 2015-12-08 | The Governing Council Of The University Of Toronto | Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix |
US9205046B2 (en) * | 2005-04-25 | 2015-12-08 | The Governing Council Of The University Of Toronto | Enhanced stability of inverse thermal gelling composite hydrogels |
US8354392B2 (en) | 2005-07-06 | 2013-01-15 | Seikagaku Corporation | Drug-introduced photo-crosslinked hyaluronic acid derived gel |
JP2010500064A (ja) * | 2006-08-08 | 2010-01-07 | フンダシオン イナスメット | 埋込み型光学システム、その開発および適用のための手順 |
US8062364B1 (en) | 2007-04-27 | 2011-11-22 | Knee Creations, Llc | Osteoarthritis treatment and device |
JP5523338B2 (ja) * | 2007-12-19 | 2014-06-18 | エヴォニク ゴールドシュミット ゲーエムベーハー | エマルジョン中の架橋ヒアルロン酸 |
US8080260B2 (en) | 2008-02-13 | 2011-12-20 | The Cleveland Clinic Foundation | Molecular enhancement of extracellular matrix and methods of use |
AU2009231634B2 (en) | 2008-04-04 | 2014-05-15 | University Of Utah Research Foundation | Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
EP2300042A4 (de) | 2008-04-30 | 2012-05-02 | Cleveland Clinic Foundation | Zusammensetzungen und verfahren zur behandlung von harninkontinenz |
CN101592772A (zh) * | 2008-05-27 | 2009-12-02 | 鸿富锦精密工业(深圳)有限公司 | 镜头装置、用于收容该镜头装置的电子装置及摄像设备 |
AU2010321743A1 (en) | 2009-11-20 | 2012-07-12 | Knee Creations, Llc | Coordinate mapping system for joint treatment |
US20110125264A1 (en) * | 2009-11-20 | 2011-05-26 | Knee Creations, Llc | Implantable devices for subchondral treatment of joint pain |
JP2013511358A (ja) | 2009-11-20 | 2013-04-04 | ニー・クリエイションズ・リミテッド・ライアビリティ・カンパニー | 関節修復のためのナビゲーションおよび位置決め機器 |
AU2010321822A1 (en) * | 2009-11-20 | 2012-07-12 | Knee Creations, Llc | Instruments for a variable angle approach to a joint |
US8821504B2 (en) | 2009-11-20 | 2014-09-02 | Zimmer Knee Creations, Inc. | Method for treating joint pain and associated instruments |
KR20120112470A (ko) * | 2009-11-20 | 2012-10-11 | 니 크리에이션스, 엘엘씨 | 관절 결함을 표적화하기 위한 기기 |
WO2011063260A1 (en) | 2009-11-20 | 2011-05-26 | Knee Creations, Llc | Bone-derived implantable devices for subchondral treatment of joint pain |
WO2011063240A1 (en) | 2009-11-20 | 2011-05-26 | Knee Creations, Llc | Implantable devices for subchondral treatment of joint pain |
US8951261B2 (en) | 2009-11-20 | 2015-02-10 | Zimmer Knee Creations, Inc. | Subchondral treatment of joint pain |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
JP2013188235A (ja) * | 2010-06-28 | 2013-09-26 | Terumo Corp | 人工弁 |
CA2831840C (en) | 2011-02-22 | 2017-08-22 | Knee Creations, Llc | Navigation and positioning systems and guide instruments for joint repair |
WO2012129461A1 (en) | 2011-03-23 | 2012-09-27 | University Of Utah Research Foundation | Methods for treating or preventing urological inflammation |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US10064671B2 (en) | 2011-06-09 | 2018-09-04 | Zimmer Knee Creations, Inc. | Instruments and devices for subchondral joint repair |
US20120316571A1 (en) | 2011-06-10 | 2012-12-13 | Knee Creations, Llc | Subchondral treatment of osteoarthritis in joints |
US9138187B2 (en) | 2011-08-07 | 2015-09-22 | Zimmer Knee Creations, Inc. | Treatment of subchondral bone by biochemical diagnosis to prevent the progression of osteoarthritis of the joint |
US9119646B2 (en) | 2011-08-07 | 2015-09-01 | Zimmer Knee Creations, Inc. | Subchondral treatment to prevent the progression of osteoarthritis of the joint |
US8623089B2 (en) | 2011-08-07 | 2014-01-07 | Zimmer Knee Creations, Inc. | Subchondral treatment of joint pain of the spine |
WO2013055891A1 (en) | 2011-10-11 | 2013-04-18 | Knee Creations Llc. | Methods and instruments for subchondral treatment of osteoarthritis in a small joint |
US9949755B2 (en) | 2012-03-30 | 2018-04-24 | Zimmer Knee Creations, Inc. | Surgical access systems, instruments and accessories |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
WO2014039995A1 (en) | 2012-09-07 | 2014-03-13 | Fibrocell Technologies, Inc. | Fibroblast compositions for treating cardial damage after an infarct |
US9504526B2 (en) | 2012-09-07 | 2016-11-29 | Zimmer Knee Creations, Inc. | Navigation instruments for subchondral bone treatment |
US9339294B2 (en) | 2012-09-07 | 2016-05-17 | Zimmer Knee Creations, Inc. | Instruments for controlled delivery of injectable materials into bone |
CZ2012842A3 (cs) | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití |
ITMI20130162A1 (it) * | 2013-02-06 | 2014-08-07 | Fidia Farmaceutici | Derivati fotoreticolati di acido ialuronico, loro processo di preparazione ed impiego |
AU2013205148B2 (en) | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
CZ304977B6 (cs) | 2013-11-21 | 2015-02-25 | Contipro Biotech S.R.O. | Nanovlákna obsahující fototvrditelný esterový derivát kyseliny hyaluronové nebo její soli, fototvrzená nanovlákna, způsob jejich syntézy, přípravek obsahující fototvrzená nanovlákna a jejich použití |
CZ305153B6 (cs) | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití |
CZ2014451A3 (cs) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití |
CZ309295B6 (cs) | 2015-03-09 | 2022-08-10 | Contipro A.S. | Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití |
CZ2015398A3 (cs) | 2015-06-15 | 2017-02-08 | Contipro A.S. | Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin |
CZ306662B6 (cs) | 2015-06-26 | 2017-04-26 | Contipro A.S. | Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití |
CN108882981B (zh) | 2016-01-29 | 2021-08-10 | 内奥瓦斯克迪亚拉公司 | 用于防止流出阻塞的假体瓣膜 |
SG10201913342UA (en) | 2016-04-27 | 2020-03-30 | Anika Therapeutics Inc | Compositions for use in treating tendon degeneration |
CZ308106B6 (cs) | 2016-06-27 | 2020-01-08 | Contipro A.S. | Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití |
AU2017204355B2 (en) | 2016-07-08 | 2021-09-09 | Mako Surgical Corp. | Scaffold for alloprosthetic composite implant |
US11337994B2 (en) | 2016-09-15 | 2022-05-24 | University Of Utah Research Foundation | In situ gelling compositions for the treatment or prevention of inflammation and tissue damage |
WO2018090148A1 (en) | 2016-11-21 | 2018-05-24 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
WO2018175788A1 (en) | 2017-03-22 | 2018-09-27 | Genentech, Inc. | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
WO2019028248A1 (en) * | 2017-08-02 | 2019-02-07 | Young Pharmaceuticals, Inc. | SYSTEMS AND METHODS FOR IMPROVING THE ADMINISTRATION OF TOPICAL ACTIVE AGENTS |
CA3073834A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US11737872B2 (en) | 2018-11-08 | 2023-08-29 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
CA3135753C (en) | 2019-04-01 | 2023-10-24 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
EP3952792A4 (de) | 2019-04-10 | 2023-01-04 | Neovasc Tiara Inc. | Herzklappenprothese mit natürlichem blutfluss |
AU2020279750B2 (en) | 2019-05-20 | 2023-07-13 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
AU2020295566B2 (en) | 2019-06-20 | 2023-07-20 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3482812D1 (de) | 1983-10-11 | 1990-08-30 | Fidia Spa | Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. |
US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5529914A (en) * | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
JP2855307B2 (ja) | 1992-02-05 | 1999-02-10 | 生化学工業株式会社 | 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法 |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
IT1263393B (it) | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare |
IT1268954B1 (it) | 1994-03-11 | 1997-03-18 | Fidia Advanced Biopolymers Srl | Processo per la preparazione di acido ialuronico mediante sintesienzimatica e relative composizioni farmaceutiche |
ITPD940054A1 (it) * | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
HU219815B (hu) | 1995-02-07 | 2001-08-28 | Fidia Advanced Biopolymers S.R.L. | Eljárás tárgyak hialuronsavval, hialuronsavszármazékokkal és félszintetikus polimerekkel történő bevonására |
IT1281886B1 (it) * | 1995-05-22 | 1998-03-03 | Fidia Advanced Biopolymers Srl | Processo per la preparazione di idrogel ottenuti da derivati chimici dell'acido ialuronico mediante irradiazioni ultraviolette e loro |
US5612321A (en) * | 1995-06-22 | 1997-03-18 | Hercules Incorporated | Antioxidant grafted polysaccharides |
US6031017A (en) | 1995-11-15 | 2000-02-29 | Seikagaku Corporation | Photocured cross-linked-hyaluronic acid gel and method of preparation thereof |
US6579978B1 (en) | 1997-04-04 | 2003-06-17 | Fidia Farmaceuti S.P.A. | Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof |
ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
US6630457B1 (en) * | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
ITPD20020064A1 (it) * | 2002-03-12 | 2003-09-12 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
-
2002
- 2002-03-12 IT IT2002PD000064A patent/ITPD20020064A1/it unknown
-
2003
- 2003-03-12 DE DE60316291T patent/DE60316291T2/de not_active Expired - Lifetime
- 2003-03-12 AU AU2003227050A patent/AU2003227050B2/en not_active Ceased
- 2003-03-12 JP JP2003574690A patent/JP4458852B2/ja not_active Expired - Fee Related
- 2003-03-12 EP EP03743875A patent/EP1519962B1/de not_active Expired - Lifetime
- 2003-03-12 AT AT03743875T patent/ATE373018T1/de active
- 2003-03-12 WO PCT/EP2003/002538 patent/WO2003076475A1/en active IP Right Grant
- 2003-03-12 CA CA2478655A patent/CA2478655C/en not_active Expired - Lifetime
- 2003-03-12 ES ES03743875T patent/ES2294305T3/es not_active Expired - Lifetime
- 2003-03-12 US US10/507,472 patent/US7462606B2/en active Active
-
2008
- 2008-10-07 US US12/246,970 patent/US8178663B2/en active Active
- 2008-10-07 US US12/246,805 patent/US8178499B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US7462606B2 (en) | 2008-12-09 |
JP2005535736A (ja) | 2005-11-24 |
DE60316291T2 (de) | 2008-06-05 |
ES2294305T3 (es) | 2008-04-01 |
JP4458852B2 (ja) | 2010-04-28 |
US20050119219A1 (en) | 2005-06-02 |
US8178499B2 (en) | 2012-05-15 |
CA2478655A1 (en) | 2003-09-18 |
US8178663B2 (en) | 2012-05-15 |
AU2003227050B2 (en) | 2008-11-06 |
AU2003227050A1 (en) | 2003-09-22 |
US20090075911A1 (en) | 2009-03-19 |
EP1519962A1 (de) | 2005-04-06 |
WO2003076475A1 (en) | 2003-09-18 |
ATE373018T1 (de) | 2007-09-15 |
CA2478655C (en) | 2012-05-08 |
ITPD20020064A1 (it) | 2003-09-12 |
EP1519962B1 (de) | 2007-09-12 |
US20090076257A1 (en) | 2009-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60316291D1 (de) | Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung | |
desJardins-Park et al. | Fibroblasts and wound healing: an update | |
Jiang et al. | Infant skin friendly adhesive hydrogel patch activated at body temperature for bioelectronics securing and diabetic wound healing | |
Ge et al. | Comprehensive assessment of Nile tilapia skin (Oreochromis niloticus) collagen hydrogels for wound dressings | |
Przekora | A concise review on tissue engineered artificial skin grafts for chronic wound treatment: can we reconstruct functional skin tissue in vitro? | |
Zhang et al. | Stimulation of wound healing using bioinspired hydrogels with basic fibroblast growth factor (bFGF) | |
Brown et al. | Expanded applications, shifting paradigms and an improved understanding of host–biomaterial interactions | |
BRPI0507622B8 (pt) | composto baseado em ácido hialurônico, processo para preparar um composto ou um sal do mesmo, composição farmacêutica, produto medicinal e dispositivo médico para uso humano ou veterinário, e,uso de composto ou de um sal do mesmo | |
EP2682138A3 (de) | Verbesserte arzneimittelbeschichtete Medizinprodukte, deren Herstellung und Verwendung | |
Konop et al. | Keratin biomaterials in skin wound healing, an old player in modern medicine: a mini review | |
Cadinoiu et al. | Silver nanoparticles biocomposite films with antimicrobial activity: In vitro and in vivo tests | |
Rodrigues Pereira et al. | Chitosan film containing mansoa hirsuta fraction for wound healing | |
Jin et al. | Preparation of foam dressings based on gelatin, hyaluronic acid, and carboxymethyl chitosan containing fibroblast growth factor-7 for dermal regeneration | |
Sugiaman et al. | Polymeric scaffolds used in dental pulp regeneration by tissue engineering approach | |
Lee et al. | Fabrication of multi-layered lidocaine and epinephrine-eluting PLGA/collagen nanofibers: in vitro and in vivo study | |
Dou et al. | Applications of tetrahedral DNA nanostructures in wound repair and tissue regeneration | |
Lyu et al. | Application of silk-fibroin-based hydrogels in tissue engineering | |
He et al. | RETRACTED: Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel | |
Chang et al. | Facile construction of hybrid hydrogels with high strength and biocompatibility for cranial bone regeneration | |
Nowacki et al. | Use of adipose‐derived stem cells to support topical skin adhesive for wound closure: A preliminary report from animal in vivo study | |
Wang et al. | Facile strategy for gelatin-based hydrogel with multifunctionalities to remodel wound microenvironment and accelerate healing of acute and diabetic wounds | |
DE202006020459U1 (de) | Zubereitung mit marinem Kollagen zur Proteinasehemmung | |
DE60111637D1 (de) | Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung | |
Busto et al. | Oleuropein-rich gellan gum/alginate films as innovative treatments against photo-induced skin aging | |
DE60011062D1 (de) | Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |